Trivarx Ltd has released a press release.
Consumer Mental Health App Initial testing phase commenced
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- US FDA advises further data needed for MEBsleep approval
- Update on Breakthrough Device Program
- Global Master License & Services Agreement with Compass
- AGM Presentation
- MEB Signs Clinical Trial Agreement with MedBridge Healthcare
Later from TrivarX
- Medibio Granted CE Mark Approval for MEBsleep
- MEB to Raise up to $3.5m By Way of a Placement and SPP
- Underwritten Share Purchase Plan Update
- MEB Begins Implementation of ilumen In the United Kingdom
- Supplementary Prospectus
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX